Skip to main content

Table 1 Median (IOR) differential cell counts (%) in BALF

From: Does unrestrained single-chamber plethysmography provide a valid assessment of airway responsiveness in allergic BALB/c mice?

  Macrophages (%) Lymphocytes (%) Neutrophils (%) Eosinophils (%) Total Cells (*105/ml)
OVA-1D-I 42.79(37.61) 12.50(17.85) 21.63(36.20) 23.20(18.42) 2.90(1.10)
OVA-1D-N 37.95(22.99) 6.50(2.10) 27.57(13.10) 23.20(15.17) 2.70(1.00)
OVA-3D-I 32.27(33.68) 7.17(11.89) 11.16(9.10) 40.36(18.54) 7.30(2.70)††
OVA-3D-N 30.41(3.58) 8.00(16.76) 8.57(12.20) 48.71(11.70) 8.80(3.50)
Control(I) 89.13(12.54)* 7.81(17.46) 0.93(3.20)* 0.00(0.00)* 1.10(0.50)*
  1. All mice were sensitized with OVA (10 ug, i.p) on days 0, 7 and 14. Mice in OVA-1D group were single-dose challenged on day 28. On day 29, responsiveness of mice was carried out with invasive measurements (OVA-1D-I group) or non-invasive measurements (OVA-1D-N group). Mice in OVA-3D group were three-dose challenged on day 28, 29, 30. On day 31, responsiveness of mice was carried out by invasive (OVA-3D-I group) or Penh measurements (OVA-3D-N group). The mice in Control (I) group were sensitized and challenged with normal saline.
  2. *P ≤ 0.01 for Control group versus OVA immunized group, Kruskal-Wallis test.
  3. P < 0.05 for OVA-3D-I group versus OVA-1D-I group, Kruskal-Wallis test.
  4. †† P ≤ 0.001 for OVA-3D-I group versus OVA-1D group (single-dose OVA challenge), Kruskal-Wallis test.